In conclusion, our preliminary study indicates that radiomic features derived from pretreatment thoracic CT images may function as non-invasive biomarkers for predicting BM in patients with ALK-rearranged NSCLC. This evidence concerns the gene ALK and non-small cell lung carcinoma.